Sonus Microsystems, Providence Health Care Ventures Collaborate on Cardiac Ultrasound Tech

Sonus Microsystems is partnering with Providence Health Care Ventures (PHCV) to accelerate the development, validation and commercialization of the former’s wearable ultrasound technology for cardiac monitoring.

Sonus Microsystems is developing a wearable ultrasound patch that reportedly represents a significant leap forward in medical diagnostic technology. Leveraging the company’s proprietary Sonus Array Technology, the device explores new approaches to remote cardiac monitoring using advanced polymer-based MEMS transducers. The patch aims to deliver real-time, AI-driven insights to healthcare providers, enabling high-resolution imaging outside traditional clinical settings.

“We are excited to partner with PHCV to advance our vision of transforming cardiac care,” Sonus Microsystems CEO Hani Eskandari said. “Leveraging PHCV’s extensive network of affiliate healthcare sites and clinical expertise will accelerate our mission to revolutionize cardiac care by allowing us to validate our product in real-world clinical settings, ultimately improving patient outcomes and enhancing healthcare delivery.”

Addressing a Critical Health Challenge

Heart failure (HF) is a chronic condition caused by the heart’s failure to pump blood well enough to provide a normal supply to the body. It is a leading cause of death and accounts for the highest rate of hospital readmissions compared to any other disease. An estimated 750,000 Canadians currently live with heart failure and 100,000 new cases are diagnosed annually. The global prevalence of chronic heart failure has doubled in the last two decades, highlighting the need for new and unique solutions.

“Partnering with Sonus aligns with our commitment to advancing innovative healthcare solutions, particularly those related to remote patient monitoring, screening, and wearable ultrasound devices,” PHCV President Brian Simmers stated. “By connecting this technology with our clinical ecosystem and fostering collaboration between innovation and care teams, we are excited to support its development and explore its potential impact on chronic disease management.”

“The Sonus Patch has the potential to transform how we monitor and screen cardiac patients,” said Dr. Nathaniel Hawkins, a clinician-scientist cardiologist specializing in heart function and heart rhythm management at St. Paul’s Hospital, and physician lead for the Regional Heart Failure Program. “Echocardiography is fundamental to diagnosing and managing heart disease, and bringing this capability to patients remotely could enable earlier detection, timely interventions, and improved long-term outcomes.”

Sonus Microsystems is working to advance ultrasound technology by developing a wearable ultrasound patch designed to provide new possibilities in remote cardiac monitoring. Leveraging its proprietary Sonus Array Technology, the company aims to create affordable, high-performance diagnostic tools.

Providence Health Care Ventures is a strategic catalyst for healthcare innovation, connecting promising medical technologies with clinical expertise. The organization partners with entrepreneurs and researchers to transform innovative healthcare concepts into viable solutions, leveraging its understanding of the Canadian healthcare ecosystem.